1190 related articles for article (PubMed ID: 17308128)
41. G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma-hemorrhage.
Hsieh YC; Yu HP; Frink M; Suzuki T; Choudhry MA; Schwacha MG; Chaudry IH
Am J Pathol; 2007 Apr; 170(4):1210-8. PubMed ID: 17392161
[TBL] [Abstract][Full Text] [Related]
42. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
43. GPR30 contributes to estrogen-induced thymic atrophy.
Wang C; Dehghani B; Magrisso IJ; Rick EA; Bonhomme E; Cody DB; Elenich LA; Subramanian S; Murphy SJ; Kelly MJ; Rosenbaum JS; Vandenbark AA; Offner H
Mol Endocrinol; 2008 Mar; 22(3):636-48. PubMed ID: 18063692
[TBL] [Abstract][Full Text] [Related]
44. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
Zhou K; Sun P; Zhang Y; You X; Li P; Wang T
Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467
[TBL] [Abstract][Full Text] [Related]
45. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
Tsai CL; Wu HM; Lin CY; Lin YJ; Chao A; Wang TH; Hsueh S; Lai CH; Wang HS
PLoS One; 2013; 8(9):e72999. PubMed ID: 24039841
[TBL] [Abstract][Full Text] [Related]
46. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.
Madak-Erdogan Z; Kieser KJ; Kim SH; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
Mol Endocrinol; 2008 Sep; 22(9):2116-27. PubMed ID: 18617595
[TBL] [Abstract][Full Text] [Related]
47. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
[TBL] [Abstract][Full Text] [Related]
48. The estrogen receptor (ER)alpha variant Delta5 exhibits dominant positive activity on ER-regulated promoters in endometrial carcinoma cells.
Bryant W; Snowhite AE; Rice LW; Shupnik MA
Endocrinology; 2005 Feb; 146(2):751-9. PubMed ID: 15528307
[TBL] [Abstract][Full Text] [Related]
49. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
[TBL] [Abstract][Full Text] [Related]
50. Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells.
Tian L; Wu Z; Zhao Y; Meng Y; Si Y; Fu X; Mu Y; Han W
J Endocrinol; 2009 Jul; 202(1):167-77. PubMed ID: 19403568
[TBL] [Abstract][Full Text] [Related]
51. Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30.
Schmidt-Wolf R; Zissel G
Anticancer Res; 2020 Jun; 40(6):3097-3108. PubMed ID: 32487604
[TBL] [Abstract][Full Text] [Related]
52. G protein-coupled receptor 30 mediates estrogen-induced proliferation of primordial germ cells via EGFR/Akt/β-catenin signaling pathway.
Ge C; Yu M; Zhang C
Endocrinology; 2012 Jul; 153(7):3504-16. PubMed ID: 22635679
[TBL] [Abstract][Full Text] [Related]
53. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.
Kumar A; Klinge CM; Goldstein RE
Int J Oncol; 2010 May; 36(5):1067-80. PubMed ID: 20372779
[TBL] [Abstract][Full Text] [Related]
54. 17 beta-estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ER alpha.
Chimento A; Sirianni R; Delalande C; Silandre D; Bois C; Andò S; Maggiolini M; Carreau S; Pezzi V
Mol Cell Endocrinol; 2010 May; 320(1-2):136-44. PubMed ID: 20132863
[TBL] [Abstract][Full Text] [Related]
55. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.
Kang L; Zhang X; Xie Y; Tu Y; Wang D; Liu Z; Wang ZY
Mol Endocrinol; 2010 Apr; 24(4):709-21. PubMed ID: 20197310
[TBL] [Abstract][Full Text] [Related]
56. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J
J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683
[TBL] [Abstract][Full Text] [Related]
57. 17β-Estradiol and Agonism of G-protein-Coupled Estrogen Receptor Enhance Hippocampal Memory via Different Cell-Signaling Mechanisms.
Kim J; Szinte JS; Boulware MI; Frick KM
J Neurosci; 2016 Mar; 36(11):3309-21. PubMed ID: 26985039
[TBL] [Abstract][Full Text] [Related]
58. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
59. Expression and signaling of G protein-coupled estrogen receptor 1 (GPER) in rat sertoli cells.
Lucas TF; Royer C; Siu ER; Lazari MF; Porto CS
Biol Reprod; 2010 Aug; 83(2):307-17. PubMed ID: 20445128
[TBL] [Abstract][Full Text] [Related]
60. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]